1st Quarter - Report

W STRATEGIES, LLC for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Patent Reform S.23 - America Invents Act of 2011 H.R. 1249 - America Invents Act of 2011

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 23 (112th), H.R. 1249 (112th)

Health Issues HCR

Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars, and a tax on medical device manufacturers. Educated staff on health complications from sleep apnea disorder. Promoted life sciences community and communicated economic and health benefits of the industry. FDA Reform Issues including issues related to reform of the 510(k) approval process. Educated staff about analysis of data related to the drug and device approval process at FDA. S. 17 - Medical Device Access and Innovation Act H.R. 436 - Protect Medical Device Innovation Act

LobbyistCovered position, as disclosed
DARREN WILLCOX House Rules Comm Assoc, Subcomm Staff Dir.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 436 (112th), S. 17 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.